Medical & affiliate disclosure: CTX Stat provides educational laboratory information and is not a substitute for professional medical advice, diagnosis, or treatment. CTX Stat may receive compensation from some outbound provider links when an affiliate program is active; provider comparisons and rankings are based on consumer fit, effective cost, access, policies, and reputation—not commission.
Question
Hello,
I had a Real-Time PCR test for Neisseria gonorrhoeae (gonorrhea) using TaqMan probes, approximately one year after receiving treatment for gonorrhea.
My result was Not Detected (Negative), and the laboratory reported an analytical detection limit of 1,000 DNA copies/mL.
I collected a midstream urine sample rather than first-catch urine.
The laboratory is internationally accredited, and its official test directory only specifies 3 mL of urine, without requiring first-catch urine.
I would like to ask:
Is a detection limit of 1,000 DNA copies/mL considered clinically adequate for diagnosing gonorrhea?
Is a negative PCR result from midstream urine generally reliable?
If the laboratory does not specifically require first-catch urine, could this indicate that its testing method is validated for midstream urine?
Considering that I was treated one year before testing, how would you assess the reliability of my negative result?
I would appreciate an answer from a specialist in molecular diagnostics or clinical microbiology.
Thank you.
Answer from CTX Stat
Hello,
Thank you for reaching out with your question. You’ve raised several important points regarding molecular testing, analytical sensitivity, and how specimen collection can influence the reliability of laboratory results.
I’ll address each of your concerns individually.
1. Is a detection limit of 1,000 DNA copies/mL clinically adequate?
A detection limit of 1,000 copies/mL indicates the approximate lowest concentration of bacterial DNA that the assay can reliably detect under its validated testing conditions.
However, analytical sensitivity and clinical sensitivity are not the same thing. A test’s analytical detection limit does not necessarily indicate how accurately it identifies infections in actual patients.
Determining whether this detection limit is clinically adequate requires reviewing the specific assay’s validation data, including its clinical sensitivity and performance with urine specimens.
2. Is a negative PCR result from midstream urine generally reliable?
For gonorrhea nucleic acid amplification testing (NAAT) in men, first-catch urine is generally the preferred collection method.
First-catch urine contains material washed from the urethra, where Neisseria gonorrhoeae may be present during a urethral infection. Midstream urine can contain fewer organisms, potentially reducing the likelihood of detection.
However, collecting midstream urine does not automatically invalidate a negative result. The reliability depends on the particular assay and whether that collection method has been evaluated and validated for its intended use.
3. Does the laboratory’s failure to specify first-catch urine mean midstream urine is acceptable?
Not necessarily.
If a laboratory’s test directory specifies only a urine volume, such as 3 mL, without identifying the preferred collection method, this does not establish that midstream urine has been validated.
The laboratory may have additional specimen collection requirements that are not included in its public directory.
The most reliable way to clarify this would be to ask the laboratory whether its particular PCR assay is validated for midstream urine or whether first-catch urine is recommended.
4. How should your negative result be interpreted approximately one year after treatment?
A negative PCR result one year after treatment can be reassuring, especially if treatment was completed appropriately and there have been no subsequent exposures.
However, several factors affect the interpretation:
- Whether the original infection was successfully treated.
- Whether there have been any subsequent exposures.
- Whether the specimen was collected according to the assay’s validated requirements.
- The clinical sensitivity of the particular PCR method.
- Whether testing was performed at the anatomical site where infection could be present.
It’s also important to recognize that a negative urine PCR test does not exclude gonorrhea infections at other anatomical sites, such as the throat or rectum.
Overall assessment
Your negative result is encouraging, but it would not be scientifically appropriate to assign a specific percentage of reliability based solely on the reported detection limit and specimen collection method.
The most important unanswered question is whether the laboratory’s particular PCR assay has been validated for midstream urine collection.
I recommend discussing these specific concerns with your doctor, particularly the reported detection limit of 1,000 copies/mL, your use of midstream rather than first-catch urine, and whether the laboratory’s testing method is validated for that specimen type. Your doctor can review the results alongside your treatment and exposure history, contact the laboratory for clarification if necessary, and determine whether repeat testing using an appropriately collected specimen would be beneficial.
I hope this explanation helps you better understand the considerations involved in interpreting your result.
Best regards,
Ryan
CTX Stat
This information is provided for educational purposes only and should not be considered a diagnosis, medical advice, or a substitute for consultation with a qualified healthcare professional.
